IndiGo Airlines on Tuesday issued a statement and said that by adhering to the standard operating procedures (SOPs) a major tragedy was averted. The incident, which took place on Sunday, has been reported to the Directorate General of Civil Aviation.
It is likely to come up for hearing tomorrow.
"At no point, safety of the passengers was compromised", said Indigo.
Earlier, the deadline for three low-priced carriers - IndiGo, GoAir and SpiceJet which now operate from T1D - to shift some of their flight operations to T2 was October-end.
The DIAL had earlier directed the airline to shift a part of its flight operations from Terminal-1 to Terminal-2 of the Indira Gandhi International Airport (IGIA). In two letters in August, one in September and the latest last week, it said the move would cause "inconvenience to passengers, increase costs and be anti-competitive" and refused to move a third of its operations.
FDA Warns About Dangers Of 'Natural' Opioid Kratom
The agency states, however, that there is no reliable evidence that kratom can be used to treat opioid use disorder. The Food and Drug Administration (FDA) issued a public advisory Tuesday about the herbal supplement kratom .
"We are still working out a common ground. otherwise the matter is in court".
IndiGo confirmed the incident.
T1 handled 24 million passengers in 2016-17 whereas its rated capacity is 20 million passengers per annum.
Delhi Airport has directed IndiGo and SpiceJet to relocate their operations in "part" and split their flight operations by shifting flights to Terminal 2 with effect from 4 January 2018, IndiGo said.
According to the airline, the passenger was "injured" and was immediately rushed to the doctor of the AAI and was administered first aid.